Oppenheimer Maintains Outperform on Camtek, Raises Price Target to $195

Benzinga Newsdesk www.benzinga.com Positive 85.1%

Neg 0% Neu 0% Pos 85.1%

Oppenheimer analyst Edward Yang maintains Camtek (NASDAQ:CAMT) with a Outperform and raises the price target from $180 to $195.